Canada Stocks Little Changed as Miners Offset Bank Slump

The video discusses a potash contract with China, highlighting market conditions and sustainability of dividends. It then covers Valeant Pharmaceuticals' financial issues, including asset sales and stock decline. Finally, it reviews ATS Automation's financial performance, noting a decrease in earnings and sales due to a lower order backlog.

What is the expected timeline for the potash contract with China according to CEO Yo?

What factors are influencing the settlement of the potash contract?

How has Valeant Pharmaceuticals attempted to address its financial challenges?

What has been the impact on Valeant Pharmaceuticals' stock price?

What reasons did ATS Automation provide for its lower fourth quarter earnings?